Literature DB >> 25540977

Estradiol, dopamine and motivation.

Katie E Yoest, Jennifer A Cummings, Jill B Becker1.   

Abstract

The gonadal hormone estradiol modulates mesolimbic dopamine systems in the female rat. This modulatory effect is thought to be responsible for the observed effects of estradiol on motivated behaviors. Dopamine acting in the nucleus accumbens is thought to be important for the attribution of incentive motivational properties to cues that predict reward delivery, while dopamine in the striatum is associated with the expression of repetitive or stereotyped behaviors. Elevated concentrations of estradiol are associated with increased motivation for sex or cues associated with access to a mate, while simultaneously attenuating motivation for food. This shift in motivational salience is important for adaptive choice behavior in the natural environment. Additionally, estradiol's adaptive effects on motivation can be maladaptive when increasing motivation for non-natural reinforcers, such as drugs of abuse. Here we discuss the effect of estradiol on mesotelencephalic dopamine transmission and subsequent effects on motivated behaviors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25540977      PMCID: PMC4793919          DOI: 10.2174/1871524914666141226103135

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  58 in total

Review 1.  Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.

Authors:  M Morissette; M Le Saux; M D'Astous; S Jourdain; S Al Sweidi; N Morin; E Estrada-Camarena; Pablo Mendez; Luis Miguel Garcia-Segura; T Di Paolo
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

Review 2.  Insights into rapid modulation of neuroplasticity by brain estrogens.

Authors:  Deepak P Srivastava; Kevin M Woolfrey; Peter Penzes
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 3.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

4.  The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats.

Authors:  D C Roberts; S A Bennett; G J Vickers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Comparing levels of cocaine cue reactivity in male and female outpatients.

Authors:  S J Robbins; R N Ehrman; A R Childress; C P O'Brien
Journal:  Drug Alcohol Depend       Date:  1999-02-01       Impact factor: 4.492

6.  Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding.

Authors:  T J Bazzett; J B Becker
Journal:  Brain Res       Date:  1994-02-21       Impact factor: 3.252

7.  Dopamine transmission increases in the nucleus accumbens of male rats during their first exposure to sexually receptive female rats.

Authors:  D Wenkstern; J G Pfaus; H C Fibiger
Journal:  Brain Res       Date:  1993-07-30       Impact factor: 3.252

8.  Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects.

Authors:  T L Thompson; R L Moss
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

9.  Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release.

Authors:  J B Becker
Journal:  Synapse       Date:  1990       Impact factor: 2.562

Review 10.  Reward and aversion in a heterogeneous midbrain dopamine system.

Authors:  Stephan Lammel; Byung Kook Lim; Robert C Malenka
Journal:  Neuropharmacology       Date:  2013-04-08       Impact factor: 5.250

View more
  55 in total

Review 1.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 2.  Striatum on the anxiety map: Small detours into adolescence.

Authors:  Tiffany Lago; Andrew Davis; Christian Grillon; Monique Ernst
Journal:  Brain Res       Date:  2016-06-06       Impact factor: 3.252

3.  Estradiol promotes the rewarding effects of nicotine in female rats.

Authors:  Rodolfo J Flores; Joseph A Pipkin; Kevin P Uribe; Adriana Perez; Laura E O'Dell
Journal:  Behav Brain Res       Date:  2016-04-06       Impact factor: 3.332

4.  Estrous cycle-induced sex differences in medium spiny neuron excitatory synaptic transmission and intrinsic excitability in adult rat nucleus accumbens core.

Authors:  Stephanie B Proaño; Hannah J Morris; Lindsey M Kunz; David M Dorris; John Meitzen
Journal:  J Neurophysiol       Date:  2018-06-27       Impact factor: 2.714

5.  Dose-dependent effects of estrogen on prediction error related neural activity in the nucleus accumbens of healthy young women.

Authors:  Janine Bayer; Tessa Rusch; Lei Zhang; Jan Gläscher; Tobias Sommer
Journal:  Psychopharmacology (Berl)       Date:  2019-11-26       Impact factor: 4.530

6.  The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc).

Authors:  Lynda Whiting; James E McCutcheon; Christina N Boyle; Mitchell F Roitman; Thomas A Lutz
Journal:  Physiol Behav       Date:  2017-03-22

Review 7.  Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Authors:  Sarah Mikelman; Natalie Mardirossian; Margaret E Gnegy
Journal:  J Chem Neuroanat       Date:  2016-08-30       Impact factor: 3.052

Review 8.  Monoamines in glioblastoma: complex biology with therapeutic potential.

Authors:  Seamus Patrick Caragher; Robert Raymond Hall; Riasat Ahsan; Atique U Ahmed
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

Review 9.  Sex differences in animal models of decision making.

Authors:  Caitlin A Orsini; Barry Setlow
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 10.  Neuropsychiatric effects of tamoxifen: Challenges and opportunities.

Authors:  Andrew M Novick; Anthony T Scott; C Neill Epperson; Christopher D Schneck
Journal:  Front Neuroendocrinol       Date:  2020-08-18       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.